Patents by Inventor Nanna Ny Kristensen

Nanna Ny Kristensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Probiotic supplement for metabolic health
    Patent number: 11963986
    Abstract: The application discloses Lactobacillus strains having a beneficial effect on the metabolic health on a mammalian subject. Further disclosed is compositions comprising such strains and the use thereof for improving the metabolic health or for lowering the blood glucose level in a mammalian subject.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: April 23, 2024
    Assignee: Novozymes A/S
    Inventors: Nanna Ny Kristensen, Alexandra Mattern, Delphine Marie Anne Saulnier, Jeffrey Schultchen, Teis Jensen, Benjamin Anderschou Holbech Jensen
  • Microbial Lysozyme for use in the Treatment of Irritable Bowel Syndrome or Inflammatory Bowel Disease
    Publication number: 20220118061
    Abstract: The present invention relates to microbial lysozyme, compositions comprising such and uses thereof.
    Type: Application
    Filed: November 2, 2021
    Publication date: April 21, 2022
    Applicant: Novozymes A/S
    Inventors: Soeren Kjaerulff, Marianne Thorup Cohn, Nanna Ny Kristensen
  • Probiotic Supplement For Metabolic Health
    Publication number: 20210393712
    Abstract: The application discloses Lactobacillus strains having a beneficial effect on the metabolic health on a mammalian subject. Further disclosed is compositions comprising such strains and the use thereof for improving the metabolic health or for lowering the blood glucose level in a mammalian subject.
    Type: Application
    Filed: October 24, 2019
    Publication date: December 23, 2021
    Applicant: Novozymes A/S
    Inventors: Nanna Ny Kristensen, Alexandra Mattern, Delphine Marie Anne Saulnier, Jeffrey Schultchen, Teis Jensen, Benjamin Anderschou Holbech Jensen
  • Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease
    Patent number: 11179447
    Abstract: The present invention relates to microbial lysozyme, compositions comprising such and uses thereof.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: November 23, 2021
    Assignee: Novozymes A/S
    Inventors: Soeren Kjaerulff, Marianne Thorup Cohn, Nanna Ny Kristensen
  • Microbial Lysozyme for use in the Treatment of Irritable Bowel Syndrome or Inflammatory Bowel Disease
    Publication number: 20190351032
    Abstract: The present invention relates to microbial lysozyme, compositions comprising such and uses thereof.
    Type: Application
    Filed: January 4, 2018
    Publication date: November 21, 2019
    Applicant: Novozymes A/S
    Inventors: Soeren Kjaerulff, Marianne Thorup Cohn, Nanna Ny Kristensen